Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
2000 participants
OBSERVATIONAL
2008-05-31
2009-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Male or female with arterial hypertension
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* intake of Atacand before study enrollment
Exclusion Criteria
* liver function impairment and/or cholestasis
* severe renal insufficiency (serum creatinine \> 265 µmol/L)
* Pregnant and lactating women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Astra Zeneca, Russia
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dmitry Zateyshchikov, MD, Prof
Role: PRINCIPAL_INVESTIGATOR
Federal State Institution of Russian President's General Management Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Arhangelsk, , Russia
Research Site
Bryansk, , Russia
Research Site
Domodedovo, , Russia
Research Site
Dzerzhinsk, , Russia
Research Site
Georgiyevsk, , Russia
Research Site
Irkutsk, , Russia
Research Site
Kazan', , Russia
Research Site
Samara, , Russia
Research Site
Severodvinsk, , Russia
Research Site
Vidnoye, , Russia
Research Site
Volgograd, , Russia
Research Site
Yekaterinburg, , Russia
Research Site
Yessentuki, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-CRU-ATA-2008/1
Identifier Type: -
Identifier Source: org_study_id